HAYWARD, Calif., Feb 26, 2010 (BUSINESS WIRE) -- Impax Laboratories, Inc.(NASDAQ: IPXL) today announced
that Arthur A. Koch, Jr., its senior vice president and chief financial
officer, will appear on the Generically Speaking panel at the RBC
Capital Markets 2010 Healthcare Conference on Tuesday, March 2nd, at
1:35 p.m. Eastern Standard time. The conference will be held at the New
York Palace Hotel, New York.
Individuals may listen to the live or archived event which will be
posted in the investor relations section of the Company's web site at www.impaxlabs.com.
This event will be archived on the Company's web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed
marketing partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward and Philadelphia facilities. For
more information, please visit the Company's Web site at: www.impaxlabs.com.
SOURCE: Impax Laboratories, Inc.
Impax Laboratories, Inc.
Mark Donohue, Sr. Director Investor Relations
215-933-3526
www.impaxlabs.com